https://d201v5jt9ylckg.cloudfront.net/288/14382/208214/208214_A388_poster_big_1.jpg
See more from Afaf Osman
This is a promising phase I study from the University of Utah combining ruxolitinib and selinexor for frontline therapy of myelofibrosis.